We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$166M
AUM Growth
+$3.17M
Cap. Flow
-$1.3M
Cap. Flow %
-0.78%
Top 10 Hldgs %
44.41%
Holding
217
New
17
Increased
28
Reduced
43
Closed
7

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.32M
2
KMI icon
Kinder Morgan
KMI
+$1.51M
3
AGN
Allergan plc
AGN
+$1.03M
4
CMCSA icon
Comcast
CMCSA
+$369K
5
VOD icon
Vodafone
VOD
+$168K

Sector Composition

Rank Sector Weight
1 Technology 18.39%
2 Energy 18.15%
3 Financials 14.33%
4 Healthcare 12.43%
5 Communication Services 11.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TURN
201
DELISTED
180 Degree Capital
TURN
$1K ﹤0.01%
200
YUMC icon
202
Yum China
YUMC
$16.5B
$1K ﹤0.01%
+40
New +$1.09K
FTR
203
DELISTED
Frontier Communications Corp.
FTR
$1K ﹤0.01%
29
CHTR icon
204
Charter Communications
CHTR
$17.3B
$0 ﹤0.01%
+1
New +$269
GEN icon
205
Gen Digital
GEN
$16.4B
-2,554
Closed -$64K
MSI icon
206
Motorola Solutions
MSI
$72.3B
-14
Closed -$1K
NVO
207
Novo Nordisk
NVO
$208B
-458
Closed -$10K
RACE icon
208
Ferrari
RACE
$69.3B
$0 ﹤0.01%
2
RMR icon
209
The RMR Group
RMR
$325M
$0 ﹤0.01%
1
SITC icon
210
SITE Centers
SITC
$225M
$0 ﹤0.01%
12
SYF icon
211
Synchrony
SYF
$24.7B
-32
Closed -$1K
SEEL
212
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
SDRL
213
DELISTED
Seadrill Limited Common Stock
SDRL
0
TIME
214
DELISTED
Time Inc.
TIME
$0 ﹤0.01%
+2
New +$30
IMN
215
DELISTED
Imation
IMN
-14
Closed
SCTY
216
DELISTED
SolarCity Corporation
SCTY
-540
Closed -$11K
PNY
217
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
-100
Closed -$6K

Similar funds

Blume Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Blume Capital Management held 217 positions worth $166M, up 1.9% from $163M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Blume Capital Management's Q4 2016 filing shows 17 new, 28 increased, 43 reduced and 7 closed positions. Its largest new stake was Teva Pharmaceuticals: 83,115 shares worth $3.01M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $2.51M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Energy and Financials.

  • Blume Capital Management's largest Q4 2016 buy was Teva Pharmaceuticals: 83,115 shares worth $3.01M.
  • Blume Capital Management added most to Kinder Morgan in Q4 2016, an estimated $1.51M increase.
  • Blume Capital Management's biggest Q4 2016 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $2.51M.
  • Blume Capital Management fully exited Gen Digital in Q4 2016, selling an estimated $64K.
  • Blume Capital Management's ten largest holdings make up 44% of its $166M portfolio in Q4 2016.
  • Blume Capital Management opened 17 new positions and closed 7 in Q4 2016.
  • Blume Capital Management's portfolio value rose 1.9% quarter-over-quarter to $166M.

Based on Blume Capital Management's 13F filing for Q4 2016, filed 30 Jan 2017.